Séripharm

Séripharm, founded in 1987 as a Product and Process Development Company aimed at synthesizing and purifying anti cancer API, is located in the close vicinity of the Le Mans University on a 20,000 m2 site. Fifteen years of industrial experience and know how have given Séripharm a strong background and expertise in the process development and production of numerous High Potent Active Pharmaceutical Ingredients (HPAI) such as Cytotoxics. Séripharm offers early-stage up to industrial custom manufacturing services mainly focused on cytotoxics and highly potent products (HPAI). Séripharm offers access to a wide range of technologies in its FDA’s inspected facility. Séripharm has the ability to combine techniques such as extraction, synthesis and semi-synthesis, preparative chromatography, crystallization and containments for HPAI up to Class 5 (OEL < 0.1-5 µg/m3) at any scale.